Islet‐Resident Memory T Cells Orchestrate the Immunopathogenesis of Type 1 Diabetes through the FABP4‐CXCL10 Axis
Xiaoping Wu,Lai Yee Cheong,Lufengzi Yuan,Leigang Jin,Zixuan Zhang,Yang Xiao,Zhiguang Zhou,Aimin Xu,Ruby LC Hoo,Lingling Shu
DOI: https://doi.org/10.1002/advs.202308461
IF: 15.1
2024-06-19
Advanced Science
Abstract:During the development of Type 1 diabetes, increased accumulation of tissue‐resident memory T (TRM) cells in pancreatic islets exert detrimental effects by sending alarming signals to recruit cytotoxic T cells thus causing β cell destruction. Mechanistically, elevated FABP4 potentiates the survival and alarming function of TRM cells by promoting fatty acid utilization and a chemokine CXCL10 secretion, respectively. Type 1 diabetes (T1D) is a chronic disease characterized by self‐destruction of insulin‐producing pancreatic β cells by cytotoxic T cell activity. However, the pathogenic mechanism of T cell infiltration remains obscure. Recently, tissue‐resident memory T (TRM) cells have been shown to contribute to cytotoxic T cell recruitment. TRM cells are found present in human pancreas and are suggested to modulate immune homeostasis. Here, the role of TRM cells in the development of T1D is investigated. The presence of TRM cells in pancreatic islets is observed in non‐obese diabetic (NOD) mice before T1D onset. Mechanistically, elevated fatty acid‐binding protein 4 (FABP4) potentiates the survival and alarming function of TRM cells by promoting fatty acid utilization and C‐X‐C motif chemokine 10 (CXCL10) secretion, respectively. In NOD mice, genetic deletion of FABP4 or depletion of TRM cells using CD69 neutralizing antibodies resulted in a similar reduction of pancreatic cytotoxic T cell recruitment, a delay in diabetic incidence, and a suppression of CXCL10 production. Thus, targeting FABP4 may represent a promising therapeutic strategy for T1D.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry